drugset

drugset / Trial / NCT00503126

Bivalirudin as a Procedural Anticoagulant in Pediatrics

NCT00503126 ↗

Phase 2 Completed 110 enrolled The Medicines Company

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Pharmacokinetics and safety of weight based bivalirudin in children

Timeline

Start: 2007-08
Primary completion: 2008-07
Completion: 2008-07

Publications

Forbes TJ, Hijazi ZM, Young G, Ringewald JM, Aquino PM, Vincent RN, Qureshi AM, Rome JJ, Rhodes JF Jr, Jones TK, Moskowitz WB, Holzer RJ, Zamora R. Pediatric catheterization laboratory anticoagulation with bivalirudin. Catheter Cardiovasc Interv. 2011 Apr 1;77(5):671-9. doi: 10.1002/ccd.22817. Epub 2011 Jan 4.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bivalirudin	Peptide	1.75 mg/kg	—

Indications

No indication recorded.